Table 2

Chest CT scan findings in patients with MAS and COVID-19

Chest CT scan findingsMASCOVID-19P value
GGOs, n (%)6 (60)47 (100) 0.028
 Apical, n (%)3 (30)31 (65.6) 0.006
 Middle, n (%)6 (60)42 (89.3)0.149
 Basal, n (%)5 (50)45 (95.7) 0.022
 Bilateral, n (%)5 (50)46 (97.8) 0.009
 Peripheral, n (%)5 (50)45 (95.7) 0.014
 Extension of GGOs, mean±SD (cm3)1295.96±572.361529.80±448.130.336
 Extension of GGOs, mean±SD (%)39.39±16.1935.80±12.590.561
Parenchymal consolidation, n (%)8 (80)29 (61.7)0.399
 Apical, n (%)0 (0)11 (23.4) 0.005
 Middle, n (%)6 (60)19 (40.4)0.429
 Basal, n (%)7 (70)23 (48.3)0.355
 Bilateral, n (%)4 (40)23 (48.3)0.867
 Peripheral, n (%)2 (20)20 (42.5)0.999
 Extension of consolidation, mean±SD (cm3)227.26±65.91353.31±122.19 0.014
 Extension of consolidation, mean±SD (%)7.15±3.148.43±4.430.477
Septal thickening, n (%)7 (70)39 (82.9)0.655
 Intralobular, n (%)6 (60)27 (57.4)0.999
 Interlobular, n (%)7 (70)38 (80.8)0.759
Bronchovascular thickening, n (%)9 (90)33 (70.2)0.237
Traction bronchiectases, n (%)1 (10)6 (12.8)0.999
Pleural effusion, n (%)4 (40)6 (12.8)0.192
Hylar lymphadenopathy, n (%)5 (50)30 (63.8)0.653
Cardiomegaly, n (%)3 (30)14 (29.8)0.999
  • GGO, ground-glass opacity; MAS, macrophage activation syndrome.